New Books in Finance cover image

Victor Roy, "Capitalizing a Cure: How Finance Controls the Price and Value of Medicines" (U California Press, 2023)

New Books in Finance

00:00

Why Did Gilead's Pricing Approach Cause an Outcry?

Gilead's pricing approach triggered a crisis in treatment access and a contentious public debate over the value of new breakthroughs. Cephaspavir is a treatment for infectious disease, hepatitis C. The price that Gilead said at the time was, you know, north in the US of $90,000 for a three month treatment.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app